Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells

Details for Australian Patent Application No. 2002345669 (hide)

Owner Gene Signal

Inventors Al-Mahmood, Salman

Agent Griffith Hack

Pub. Number AU-B-2002345669

PCT Number PCT/FR02/02067

PCT Pub. Number WO2002/103014

Priority 0107805 14.06.01 FR

Filing date 14 June 2002

Wipo publication date 2 January 2003

Acceptance publication date 2 February 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

6 March 2003 Complete Application Filed

  Priority application(s): 0107805 14.06.01 FR

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002345669

2 February 2006 Application Accepted

  Published as AU-B-2002345669

18 May 2006 Assignment before Grant

  Gene Signal The application has been assigned to Gene Signal International SA

1 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002345670-MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571

2002345668-DIGITAL BEAM HOLOGRAPHIC DISPLAY SYSTEM